A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers.
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
[18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis
- Status
- TERMINATED
- Phase
- NA
Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy
- Status
- COMPLETED
- Phase
- PHASE1
A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Sunscreen Based on Bioadhesive Nanoparticles
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma
- Status
- TERMINATED
- Phase
- NA
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of MGD009 in B7-H3-expressing Tumors
- Status
- TERMINATED
- Phase
- PHASE1